19-41004161-A-G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_000767.5(CYP2B6):​c.332A>G​(p.Tyr111Cys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000344 in 958,204 control chromosomes in the GnomAD database, with no homozygous occurrence. 15/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., cov: 25)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

CYP2B6
NM_000767.5 missense, splice_region

Scores

1
3
15
Splicing: ADA: 0.005061
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.943

Publications

2 publications found
Variant links:
Genes affected
CYP2B6 (HGNC:2615): (cytochrome P450 family 2 subfamily B member 6) This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAdExome4 at 31 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2B6NM_000767.5 linkc.332A>G p.Tyr111Cys missense_variant, splice_region_variant Exon 2 of 9 ENST00000324071.10 NP_000758.1 P20813-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2B6ENST00000324071.10 linkc.332A>G p.Tyr111Cys missense_variant, splice_region_variant Exon 2 of 9 1 NM_000767.5 ENSP00000324648.2 P20813-1
CYP2B6ENST00000593831.1 linkc.104A>G p.Tyr35Cys missense_variant, splice_region_variant Exon 1 of 5 2 ENSP00000470582.1 M0QZJ2
CYP2B6ENST00000598834.2 linkn.233A>G splice_region_variant, non_coding_transcript_exon_variant Exon 2 of 10 5 ENSP00000496294.1 A0A2R8YFA4
CYP2B6ENST00000594187.1 linkn.-218A>G upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0000184
AC:
2
AN:
108522
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.0000360
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000171
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000798
AC:
2
AN:
250682
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0000624
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000883
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000365
AC:
31
AN:
849682
Hom.:
0
Cov.:
36
AF XY:
0.0000278
AC XY:
12
AN XY:
430934
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
19640
American (AMR)
AF:
0.00
AC:
0
AN:
37012
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14948
East Asian (EAS)
AF:
0.00
AC:
0
AN:
15796
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76176
European-Finnish (FIN)
AF:
0.0000305
AC:
1
AN:
32818
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3750
European-Non Finnish (NFE)
AF:
0.0000470
AC:
29
AN:
617480
Other (OTH)
AF:
0.0000312
AC:
1
AN:
32062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000184
AC:
2
AN:
108522
Hom.:
0
Cov.:
25
AF XY:
0.0000203
AC XY:
1
AN XY:
49218
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000360
AC:
1
AN:
27756
American (AMR)
AF:
0.00
AC:
0
AN:
6990
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3100
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3250
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2972
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3458
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
178
European-Non Finnish (NFE)
AF:
0.0000171
AC:
1
AN:
58546
Other (OTH)
AF:
0.00
AC:
0
AN:
1444
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.350
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000740
Hom.:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 20, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.332A>G (p.Y111C) alteration is located in exon 2 (coding exon 2) of the CYP2B6 gene. This alteration results from a A to G substitution at nucleotide position 332, causing the tyrosine (Y) at amino acid position 111 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.043
T;T;T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.32
.;T;T
M_CAP
Benign
0.015
T
MetaRNN
Uncertain
0.48
T;T;T
MetaSVM
Benign
-0.58
T
MutationAssessor
Uncertain
2.4
M;M;.
PhyloP100
0.94
PrimateAI
Benign
0.48
T
PROVEAN
Pathogenic
-5.0
.;D;.
REVEL
Benign
0.24
Sift
Benign
0.030
.;D;.
Sift4G
Benign
0.070
.;T;T
Polyphen
1.0
D;D;.
Vest4
0.47, 0.46
MVP
0.84
MPC
0.40
ClinPred
0.65
D
GERP RS
0.048
PromoterAI
-0.029
Neutral
Varity_R
0.48
gMVP
0.43
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0051
dbscSNV1_RF
Benign
0.12
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780098230; hg19: chr19-41510066; API